List of Figures:
Figure 4-1: Global - Vaccine Market by Source of Funding (%), 2005 to 2010
Figure 6-1: Global - Vaccine Market (Billion US$), 2009-2012
Figure 7-1: Global - Basic Pediatric Vaccine Market (Million US$), 2007-2012
Figure 7-2: Global - Enhanced Pediatric Vaccine Market (Billion US$), 2007-2012
Figure 7-3: Global - Proprietary Pediatric Vaccine Market (Billion US$), 2007-2012
Figure 7-4: Global - Share of Adult Vaccine Sales in Vaccine Market (2008 & 2009)
Figure 7-5: Global - Adult Vaccine Market (Billion US$), 2009-2012
Figure 8-1: Global - Pneumococcal Vaccine Market (Billion US$), 2009-2012
Figure 8-2: Global - Number of Polio Incidences (2007-2009)
Figure 8-3: Global - Polio Vaccine Market (Million US$), 2004 & 2011
Figure 8-4: Global - Varicella Vaccine Market (Million US$), 2007 & 2008
Figure 8-5: Global - Meningococcal Vaccine (Million US$), 2009 & 2013
Figure 8-6: Global - Rotavirus Vaccine Market (Million US$), 2009 & 2010
Figure 8-7: Global - Rotavirus Vaccine Market by Region (%), 2010
Figure 8-8: Global - Number of Diphtheria Incidences by Region (2008)
Figure 8-9: Global - Number of Pertussis Incidences by Region (2008)
Figure 8-10: Global - Number of nTetanus Incidences by Region (2008)
Figure 8-11: Global - Number of tTetanus Incidences by Region (2008)
Figure 8-12: Global - Number of Measles Incidences by Region (2008)
Figure 8-13: Global - Number of Mumps Incidences by Region (2008)
Figure 8-14: Global - Number of Rubella Incidences by Region (2008)
Figure 8-15: Global - Number of Tuberculosis Incidences by Region (‘000), 2008
Figure 9-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2006
Figure 9-2: Global - Hepatitis B Vaccine Market (Billion US$), 2009-2012
Figure 9-3: Global - Yellow Fever Vaccine Market (Million US$), 2010 & 2013
Figure 9-4: Global - Japanese Encephalitis Market (Million US$), 2009-2012
Figure 9-5: Global - R&D Investment in AIDS Vaccine Development (Million US$), 2006-2009
Figure 9-6: Global - Sources for Funding in HIV Vaccine R&D (%), 2009
Figure 9-7: Global - Cancer Vaccine Market (Billion US$), 2009-2012
Figure 9-8: Global - Number of Cancer Vaccines in Various Phases of Clinical Developments by Type (Aug 2005)
Figure 9-9: Global - Seasonal Influenza Vaccine Market (Billion US$), 2009-2012
Figure 10-1: Global - Vaccine Market by Region (%), 2009
Figure 10-2: Global - Forecast for Vaccine Market by Region (%), 2012
Figure 10-3: US - Vaccine Market (Billion US$), 2008-2012
Figure 10-4: US - Pediatric Vaccine Market (Billion US$), 2010-2012
Figure 10-5: US - Hepatitis Vaccine Market (Billion US$), 2009-2012
Figure 10-6: US - Influenza Vaccine Production by Player (%), 2009
Figure 10-7: US - Influenza Vaccine Production and Consumption (Million Doses), 2004-2005 to 2008-2009
Figure 10-8: US - Influenza Vaccine Sales by Provider (%), 2007-2008
Figure 10-9: US - Influenza Vaccine Market (Million US$), 2009-2012
Figure 10-10: US - Travel Vaccine Market (Million US$), 2009-2012
Figure 10-11: US - Developmental Vaccine Market (Million US$), 2009-2012
Figure 10-12: Europe - Vaccine Market (Billion US$), 2009-2012
Figure 10-13: Europe - Share of Key Players in Vaccine Market (2008)
Figure 10-14: China - Vaccine Market (Billion US$), 2008-2012
Figure 10-15: China - Share of Key Players in Vaccine Market (2008)
Figure 10-16: China - Influenza Vaccine Market (Million US$), 2008-2012
Figure 10-17: India - Share of Domestic Consumption and Exports in Vaccine Market (2009)
Figure 10-18: India - Share of Private Sector in Domestic Vaccine Market (2008)
Figure 10-19: India - Vaccine Market (Million US$), 2008-09 to 2011-12
Figure 10-20: India - Share of Key Players in Vaccine Market (2006-07)
Figure 10-21: Japan - Vaccine Market (Billion US$), 2008-2012
Figure 10-22: Japan - Influenza Vaccine Production (Million Doses), 2007-08 & 2008-09
Figure 10-23: Japan - Share of Domestic and Foreign Players in Vaccine Market (2009)
Figure 10-24: Japan - Vaccine Market by Segment (%), 2009
Figure 10-25: Brazil - Vaccine Market (Billion BRL), 2009-2012
Figure 10-26: Brazil - Share of Public and Private Sector in Vaccine Market (2004)
Figure 10-27: Brazil - Share of Key Players in Private Sector Vaccine Market (2008)
Figure 11-1: Global - Dose Consumption and Revenue by Regional Income (%), 2005
Figure 14-1: Global - Vaccine Market by Player (%), 2009
List of Tables:
Table 8-1: Global - Pneumococcal Vaccine Supply
Table 8-2: Global - Leading DTP Vaccine Brands (Million US$), 2008
Table 8-3: Global - Leading MMR Vaccine Brands (Million US$), 2008
Table 9-1: Global - Number of HIV/AIDS Patients by Region (2008)
Table 9-2: US - Number of New Cancer Cases and Deaths (2009)
Table 9-3: Global - Five Year Relative Survival Rates by Stage of Cancer Diagnosis (%)
Table 9-4: Global - List of Launched and Under-development Cancer Vaccines by Indication
Table 9-5: Global - Top 5 Companies’ Pandemic Influenza (H1N1) Vaccine Sales (Million US$), 2009
Table 10-1: China - Number of Reported Cases of Diseases Preventable by Vaccine (2008 & 2009)
Table 10-2: China - Vaccine Classification
Table 10-3: China - Annual Pediatric Vaccine Doses Requirement (Million)
Table 10-4: China - Revenues of Some Vaccine Manufacturing Biological Companies (Million RMB), 2006
Table 10-5: India - Sales of Top Five Vaccine Companies (Million US$), 2008-09
Table 10-6: Japan - Sales of Top Domestic Vaccine Manufacturers (Million JPY)
Table 10-7: Japan - Sales of Top Foreign Vaccine Players (Million JPY)
Table 10-8: Brazil - Public and Private Sector Vaccine Market (Million BRL)
Table 11-1: Health Statistics in Developed and Developing Countries (%)
Table 12-1: Global - Key Mergers & Acquisitions in Vaccine Market (2005 to 2009)
Table 13-1: Global - Top Launched Vaccine Brand Sales (Billion US$), 2009 & 2012
Table 13-2: Global - Forecast for Top Vaccine Brand Sales Under-development (Million US$), 2012
Table 14-1: Sanofi Aventis - Strengths and Weaknesses
Table 14-2: Novartis - Strengths and Weaknesses
Table 14-3: GSK - Strengths and Weaknesses
Table 14-4: Pfizer - Strengths and Weaknesses
Table 14-5: Global - Major Vaccine Companies (Segmentation by Revenue)
